MiNK Therapeutics Inc (INKT) Stock Price

7.25 ▼ -0.2999 (-3.97%)
Open: 7.37 Vol: 2.2K Day's range: 7.25 - 7.37 Jun 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
INKT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 7.31▼ 7.31▼ 7.25▼ 7.36▼ 7.24▲
MA10 7.23▼ 7.20▲ 7.20▲ 7.25▼ 7.41▼
MA20 7.31▼ 7.31▼ 7.31▼ 7.28▼ 8.31▼
MA50 7.45▼ 7.48▼ 7.70▼ 7.57▼ 7.97▼
MA100 7.91▼ 8.01▼ 8.28▼ 8.28▼ 9.52▼
MA200 8.98▼ 8.58▼ 8.40▼ 7.75▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.015▲ 0.017▲ 0.024▲ 0.052▲ -0.139▼
RSI 46.235▼ 46.372▼ 46.172▼ 47.964▼ 45.335▼
STOCH 78.038     58.141     41.997     70.670     28.781    
WILL %R -66.576     -66.576     -66.576     -39.780     -72.997    
CCI -19.121     -31.780     -33.147     50.540     -55.568    
Latest Filters Detected On INKT
RSI $INKT RSI(14) Crossed Below 50 Set Alert
MA $INKT Price Crossed Below MA(26) Set Alert
MA $INKT Price Crossed Below MA(7) Set Alert
▼ GAP $INKT Open Gap Down %2 Set Alert
MiNK Therapeutics Inc News
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
Tuesday, June 10, 2025 10:33 AM
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its ...
MiNK Therapeutics Receives NIAID Grant to Advance Allo-iNKT Cell Therapy for Graft-Versus-Host Disease Treatment
Monday, June 02, 2025 06:40 AM
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT ...
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
Monday, June 02, 2025 06:29 AM
Non-dilutive NIH funding supports development of MiNK’s allogeneic iNKT platform for immune regulation in high-risk HSCT settingsNEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc.
INKT historical stock data
date open high low close volume
13/06/25 7.37 7.37 7.25 7.25 2,197
12/06/25 7.3005 7.5499 7.3005 7.5499 893
11/06/25 7.16 7.59 7.16 7.59 2,016
09/06/25 7.20 7.20 7.16 7.16 1,226
06/06/25 7.38 7.41 7.255 7.255 3,632
05/06/25 7.29 7.29 7.29 7.29 1,673
04/06/25 6.98 7.3599 6.98 7.102 4,548
03/06/25 7.20 7.24 7.11 7.13 4,381
02/06/25 6.98 7.2511 6.98 7.17 4,920
30/05/25 7.03 7.03 6.98 7.03 1,620
Quote Details
52wk Low:4.56
52wk High:13.79
Vol:2.2K
Avg Vol(3m):70.9K
1Y Chng:-18.54%
1M Chng:-2.71%
Add to Watch List
More Information
Index US Composite
Market Cap. 30.25M